Xolair 150 MG/ML 1S
Ended Awarded
- Contract number
- SPE2DR26FBUKA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,454
Award facts
- Contract value 100% obligated
- $31,453.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $31,453.92 delivery order to DMS Pharmaceutical Group Inc. on June 16, 2026, for Xolair 150 mg/ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical is a woman-owned small business. The order is firm fixed price with an ultimate completion date of June 24, 2026. Place of performance is Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DR26FBUKA?
SPE2DR26FBUKA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 16, 2026.
How much is contract SPE2DR26FBUKA worth?
The government has obligated $31,454 on SPE2DR26FBUKA.
Is contract SPE2DR26FBUKA an order under another contract?
Yes. SPE2DR26FBUKA is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBUKA competed?
The extent of competition for SPE2DR26FBUKA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award